本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Context Therapeutics Inc.

0.8600
-0.0087-1.00%
成交量:5.59万
成交额:4.80万
市值:7,714.56万
市盈率:-2.43
高:0.8800
开:0.8800
低:0.8497
收:0.8687
数据加载中...
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/10

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/30

SEC问询函

Form CORRESP - Correspondence
2024/05/24

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/06

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/31

重要事件披露

Form 8-K - Current report